FIELD: medicine; pharmacology.
SUBSTANCE: purpose of given invention lies in development of stable preparative form of injection phenotropyl with high biologicale accessibility, and related method of production. Set purpose is achieved by solution-like injection agent containing phenotropyl and solvent consisting of mixed polyethylene glycol (PEG), ethyl alcohol and injection water. Solution is made phenotropyl dissolved in ethyl alcohol, added with polyethylene glycol and injection water followed with microfiltering sterilisation, preferably through filter with pore sizes 0.1 -1.0 mcm, most preferably through filter with pore sizes 0.45 mcm.
EFFECT: reduced disabling probability and hospitalisation time.
5 ex, 2 tbl, 4 cl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION IN FORM OF SOLUTION FOR INJECTION AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2524651C1 |
| PHARMACEUTICAL COMPOSITION ELICITING NOOTROPIC ACTIVITY AND METHOD FOR ITS PREPARING | 2003 |
|
RU2240783C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE NEW COMPOSITION | 2017 |
|
RU2696277C2 |
| TABLETTED PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING IT | 2013 |
|
RU2539375C1 |
| 4-PHENYL PYRROLIDINONE-2 DERIVATIVE, NOOTROPIC COMPOSITION THEREOF, METHOD FOR PRODUCING THEREOF AND METHOD PREVENTIVE TREATMENT OF NERVOUS SYSTEM DISORDERS | 2015 |
|
RU2611623C2 |
| CEREBRAL PROTECTIVE AND STRESS-PROTECTIVE MEDICINAL AGENT "NOOTRIL" AS INJECTION SOLUTION | 2003 |
|
RU2268711C2 |
| SUBSTANCE EXHIBITING NOOTROPIC ACTIVITY | 1990 |
|
RU2050851C1 |
| NOOTROPIC ANTIALCOHOLIC DRUG | 1985 |
|
RU2020937C1 |
| QUINAZOLINE DERIVATIVES, POSSESSING NOOTROPIC AND ANTIHYPOXIC ACTIVITY | 2012 |
|
RU2507198C1 |
